SOPHiA GENETICS Future Growth
Future criteria checks 2/6
SOPHiA GENETICS is forecast to grow earnings and revenue by 22.7% and 24% per annum respectively. EPS is expected to grow by 23% per annum. Return on equity is forecast to be -76.3% in 3 years.
Key information
22.7%
Earnings growth rate
23.0%
EPS growth rate
Healthcare Services earnings growth | 28.1% |
Revenue growth rate | 24.0% |
Future return on equity | -76.3% |
Analyst coverage | Low |
Last updated | 08 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 132 | -45 | N/A | -9 | 3 |
12/31/2025 | 101 | -55 | N/A | -25 | 4 |
12/31/2024 | 79 | -63 | N/A | -36 | 4 |
3/31/2024 | 64 | -73 | -57 | -48 | N/A |
12/31/2023 | 62 | -79 | -58 | -49 | N/A |
9/30/2023 | 59 | -69 | -58 | -48 | N/A |
6/30/2023 | 54 | -78 | -68 | -58 | N/A |
3/31/2023 | 51 | -82 | -77 | -67 | N/A |
12/31/2022 | 48 | -87 | -80 | -70 | N/A |
9/30/2022 | 45 | -95 | -84 | -75 | N/A |
6/30/2022 | 44 | -93 | -77 | -69 | N/A |
3/31/2022 | 42 | -86 | -73 | -65 | N/A |
12/31/2021 | 40 | -74 | -65 | -58 | N/A |
9/30/2021 | 37 | -63 | -58 | -52 | N/A |
6/30/2021 | 34 | -52 | -51 | -46 | N/A |
3/31/2021 | 30 | -41 | -39 | -35 | N/A |
12/31/2020 | 28 | -39 | -35 | -32 | N/A |
12/31/2019 | 25 | -34 | -35 | -32 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 90B is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 90B is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 90B is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 90B's revenue (24% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: 90B's revenue (24% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 90B is forecast to be unprofitable in 3 years.